Search results
Results From The WOW.Com Content Network
Named lectures include the Sir Arthur Hurst lecture and the Sir Francis Avery Jones BSG Research medallist. Recent presidents have been Hermon Dowling (1996–1997), Chris Hawkey (2010), Jon Rhodes (2011–12), Ian Gilmore (2013–14), Ian Forgacs (2014–16), Martin Lombard (2016–18), Cathryn Edwards (2018–20), Alastair McKinlay (2020-22 ...
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, with Crohn's disease and ulcerative colitis (UC) being the principal types. [3] Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas UC primarily affects the colon ...
It is important and occasional difficult to distinguish SCAD from inflammatory bowel disease (IBD). [1] [7] Biopsies reveal histologic findings that are identical in both conditions. [1] However, ulcerative colitis usually affects the rectum and inflammation in IBD extends to areas of the colon without diverticulosis. [1]
New research suggests patients with an average risk of colon cancer may only need to undergo a colonoscopy screening every 15 years instead of the recommended 10.. Swedish researchers found that ...
Ulcerative colitis (UC) is one of the two types of inflammatory bowel disease (IBD), with the other type being Crohn's disease. [1] It is a long-term condition that results in inflammation and ulcers of the colon and rectum. [1] [7] The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood (hematochezia). [1]
Inflammatory Bowel Diseases is a monthly peer-reviewed medical journal covering all aspects of inflammatory bowel disease. It was established in 1995 and is published by Oxford University Press. [1] It is the official journal of the Crohn's & Colitis Foundation. The editor-in-chief is Fabio Cominelli (Case Western Reserve University). [2]
Some of the most common conditions managed by gastroenterologists include gastroesophageal reflux disease, gastrointestinal bleeding, irritable bowel syndrome, inflammatory bowel disease (IBD) which includes Crohn's disease and ulcerative colitis, peptic ulcer disease, gallbladder and biliary tract disease, hepatitis, pancreatitis, colitis ...
The anti-TNF-α monoclonal antibody infliximab is a major biological therapy for inflammatory bowel disease Biological therapy, the use of medications called biopharmaceuticals or biologics that are tailored to specifically target an immune or genetic mediator of disease, plays a major role in the treatment of inflammatory bowel disease. [ 1 ]